CD274 and endometrial cancer: Early-phase clinical trials are currently investigating the safety and efficacy of PD-1/PD-L1 inhibitors in conjunction with radiotherapy for advanced or recurrent endometrial cancer (NCT04214067), although mature data are still awaited (81).